What it's for (Indications)
- Lactobacillus reuteri is a probiotic microorganism that has been investigated and utilized for various gastrointestinal and systemic health benefits.
- Clinically, it is indicated for the management of infantile colic, demonstrating efficacy in reducing crying time in breastfed infants.
- It is also employed in the prevention and treatment of certain types of diarrhea, including acute infectious diarrhea in children and antibiotic-associated diarrhea.
- Furthermore, L.
- reuteri may be beneficial in promoting overall gut health, balancing the gut microbiota, and supporting immune function.
- Emerging evidence suggests potential roles in reducing gastrointestinal discomfort, such as occasional constipation or abdominal pain, and modulating inflammatory responses within the gut.
- Its use is often recommended to restore microbial balance following disturbances or to maintain a healthy gut ecosystem.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of Lactobacillus reuteri varies significantly depending on the specific strain (e.g., L. reuteri DSM 17938, L. reuteri ATCC PTA 6475), the formulation (e.g., drops, chewable tablets, capsules), and the intended clinical indication. For infantile colic, commonly used dosages range from 1 x 10^8 to 2 x 10^8 Colony Forming Units (CFU) once daily. In the context of diarrhea prevention or treatment, dosages might range from 1 x 10^9 to 5 x 10^9 CFU daily, often divided into one or two doses. It is crucial to follow the specific instructions provided by the manufacturer of the Lactobacillus reuteri product, as CFU counts and recommended regimens can differ substantially. Healthcare professionals should be consulted for personalized dosage recommendations, especially when used for specific medical conditions or in vulnerable populations, to ensure optimal therapeutic benefit and safety. |
Safety & Warnings
Common Side Effects
- Lactobacillus reuteri is generally well-tolerated, with most reported side effects being mild and transient.
- The most common adverse reactions are related to the gastrointestinal system and may include abdominal discomfort, bloating, flatulence, or mild changes in bowel habits, such as looser stools.
- These symptoms are typically mild and often resolve as the body adjusts to the probiotic supplementation.
- In very rare instances, individuals with extreme sensitivities or underlying severe medical conditions might experience more pronounced gastrointestinal upset.
- Allergic reactions, though exceptionally rare, cannot be entirely ruled out and could manifest as skin rashes, itching, or, in severe cases, anaphylaxis.
- Patients experiencing persistent or severe adverse effects should discontinue use and consult a healthcare professional.
Serious Warnings
- Black Box Warning: NO BLACK BOX WARNING **Serious Warnings:** While Lactobacillus reuteri does not carry an FDA-mandated Black Box Warning, significant caution and careful clinical evaluation are imperative before administration, particularly in vulnerable populations. There is a theoretical, albeit rare, risk of systemic infection (bacteremia or fungemia) in severely immunocompromised individuals, critically ill patients, those with a compromised intestinal barrier (e.g., severe short bowel syndrome, necrotizing enterocolitis, or conditions leading to increased intestinal permeability), and patients with central venous catheters. In these high-risk groups, the potential benefits of probiotic use must be meticulously weighed against the potential for adverse events, which could be life-threatening. Clinical judgment is essential, and close monitoring for signs of infection (e.g., fever, chills, persistent abdominal pain, changes in mental status) is strongly recommended. Discontinue Lactobacillus reuteri immediately if any such signs develop and initiate appropriate medical management. Always consult with a healthcare professional to determine suitability, especially in individuals with severe underlying medical conditions or those receiving intensive care, to avoid potential complications arising from bacterial translocation or systemic dissemination. The administration of probiotics to very low birth weight or premature infants also warrants extreme caution and should only occur under strict medical supervision due to their immature immune systems and gut barriers.
- While Lactobacillus reuteri is generally considered safe for use in healthy individuals, certain precautions and warnings apply.
- Patients with compromised immune systems (e.
- g.
- , due to chemotherapy, HIV/AIDS, organ transplantation, or corticosteroid use), those with severe underlying medical conditions, or individuals with a history of serious infections should exercise caution and consult a healthcare professional before initiating supplementation.
- There is a theoretical, albeit low, risk of probiotic bacteremia or fungemia, particularly in these vulnerable populations.
- Patients with short bowel syndrome or those with central venous catheters should also be closely monitored, as there have been isolated reports of systemic infections in such high-risk groups, although direct causation is often difficult to establish.
- Discontinue use if any signs of infection (e.
- g.
- , fever, chills, persistent abdominal pain) or allergic reactions occur and seek immediate medical attention.
- Always ensure the product is stored as directed to maintain viability and efficacy.
How it Works (Mechanism of Action)
Lactobacillus reuteri exerts its beneficial effects through a multifaceted mechanism of action within the host's gastrointestinal tract and systemically. As a commensal bacterium, it contributes to the modulation of the gut microbiota by competing with pathogenic microorganisms for nutrients and adhesion sites on the intestinal epithelium. It produces antimicrobial substances, notably reuterin and reutericyclin, which inhibit the growth of various pathogenic bacteria, yeasts, fungi, and protozoa. L. reuteri also plays a crucial role in immune modulation, interacting with intestinal immune cells (e.g., dendritic cells, macrophages) to influence cytokine production, thereby promoting a balanced inflammatory response and potentially enhancing systemic immunity. Furthermore, it can strengthen the intestinal barrier function by increasing mucin production and tight junction protein expression, reducing gut permeability. It may also improve digestive processes by producing enzymes and aiding in nutrient absorption, and contribute to the synthesis of certain vitamins.
Commercial Brands (Alternatives)
No other brands found for this formula.